Metis Global Partners LLC Cuts Stock Holdings in Teleflex Incorporated (NYSE:TFX)

Metis Global Partners LLC reduced its position in shares of Teleflex Incorporated (NYSE:TFX) by 36.3% in the 4th quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 2,278 shares of the medical technology company’s stock after selling 1,299 shares during the period. Metis Global Partners LLC’s holdings in Teleflex were worth $405,000 at the end of the most recent quarter.

Several other large investors also recently bought and sold shares of TFX. Janus Henderson Group PLC grew its position in shares of Teleflex by 2.8% in the third quarter. Janus Henderson Group PLC now owns 5,376,452 shares of the medical technology company’s stock valued at $1,329,704,000 after purchasing an additional 147,147 shares in the last quarter. FMR LLC grew its position in shares of Teleflex by 70.1% in the third quarter. FMR LLC now owns 269,490 shares of the medical technology company’s stock valued at $66,650,000 after purchasing an additional 111,086 shares in the last quarter. Point72 Asset Management L.P. grew its position in shares of Teleflex by 31.2% in the third quarter. Point72 Asset Management L.P. now owns 407,442 shares of the medical technology company’s stock valued at $100,768,000 after purchasing an additional 96,958 shares in the last quarter. Parkman Healthcare Partners LLC purchased a new stake in shares of Teleflex in the third quarter valued at approximately $23,778,000. Finally, Robeco Institutional Asset Management B.V. grew its position in shares of Teleflex by 1,401.5% in the fourth quarter. Robeco Institutional Asset Management B.V. now owns 41,726 shares of the medical technology company’s stock valued at $7,426,000 after purchasing an additional 38,947 shares in the last quarter. 95.62% of the stock is currently owned by hedge funds and other institutional investors.

Analyst Upgrades and Downgrades

TFX has been the topic of a number of recent analyst reports. Royal Bank of Canada cut Teleflex from an “outperform” rating to a “sector perform” rating and decreased their price objective for the company from $220.00 to $155.00 in a report on Friday, February 28th. Needham & Company LLC reiterated a “hold” rating on shares of Teleflex in a report on Monday, December 16th. Bank of America cut Teleflex from a “neutral” rating to an “underperform” rating and decreased their price objective for the company from $235.00 to $140.00 in a report on Tuesday. Citizens Jmp cut Teleflex from an “outperform” rating to a “market perform” rating in a report on Thursday, February 27th. Finally, Truist Financial decreased their price target on Teleflex from $200.00 to $149.00 and set a “hold” rating on the stock in a research note on Monday. One analyst has rated the stock with a sell rating, nine have assigned a hold rating and two have issued a buy rating to the company’s stock. According to data from MarketBeat.com, the company currently has a consensus rating of “Hold” and a consensus target price of $182.63.

Teleflex Stock Up 2.7 %

Shares of NYSE TFX opened at $134.38 on Thursday. The stock has a market cap of $6.24 billion, a P/E ratio of 26.71, a PEG ratio of 1.73 and a beta of 1.16. The company has a current ratio of 2.42, a quick ratio of 1.39 and a debt-to-equity ratio of 0.37. Teleflex Incorporated has a 12-month low of $128.55 and a 12-month high of $249.90. The business’s fifty day simple moving average is $172.79 and its 200-day simple moving average is $202.69.

Teleflex (NYSE:TFX) last announced its quarterly earnings data on Thursday, February 27th. The medical technology company reported $3.89 earnings per share (EPS) for the quarter, beating the consensus estimate of $3.86 by $0.03. The business had revenue of $795.40 million for the quarter, compared to analysts’ expectations of $813.24 million. Teleflex had a return on equity of 14.19% and a net margin of 7.85%. As a group, equities analysts predict that Teleflex Incorporated will post 13.98 EPS for the current fiscal year.

Teleflex Dividend Announcement

The business also recently disclosed a quarterly dividend, which will be paid on Monday, March 17th. Stockholders of record on Friday, March 7th will be paid a $0.34 dividend. This represents a $1.36 annualized dividend and a dividend yield of 1.01%. The ex-dividend date is Friday, March 7th. Teleflex’s payout ratio is currently 95.77%.

About Teleflex

Teleflex Incorporated designs, develops, manufactures, and supplies single-use medical devices for common diagnostic and therapeutic procedures in critical care and surgical applications worldwide. The company provides vascular access products that comprise Arrow branded catheters, catheter navigation and tip positioning systems, and intraosseous access systems for the administration of intravenous therapies, the measurement of blood pressure, and the withdrawal of blood samples through a single puncture site.